Yes, patients with a first-degree relative who had breast cancer should undergo mammographic screening, and they should start earlier than average-risk women.
Women with a first-degree family history of breast cancer should begin annual mammographic screening at age 40, or earlier if their calculated lifetime risk is ≥20%, and should be evaluated for breast cancer risk no later than age 30 to determine if they qualify for enhanced screening protocols 1.
Risk Stratification and Screening Approach
Having a first-degree relative with breast cancer approximately doubles your patient's breast cancer risk compared to women without family history. The key is determining whether your patient falls into a moderate-risk or high-risk category:
For Moderate-Risk (Family History Alone):
- Start annual mammography at age 40 1
- Cancer detection rates in women with first-degree family history are similar to women a decade older without such history 2
- These women experience higher rates of screen-detected cancers (9.0% vs 6.3% cumulative risk ages 50-75) compared to those without family history 3
For High-Risk (≥20% Lifetime Risk):
Your patient needs formal risk assessment by age 30 to determine if they meet criteria for:
- Calculated lifetime risk ≥20% using validated models (Gail, Tyrer-Cuzick, BRCAPRO)
- Genetic testing consideration, particularly if the relative was diagnosed young (≤50 years) or if patient has Ashkenazi Jewish ancestry 1
If high-risk criteria are met:
- Begin annual mammography PLUS annual contrast-enhanced breast MRI starting at age 30 or earlier 1
- MRI provides additional cancer detection in high-risk women that mammography alone misses
Important Clinical Considerations
Timing matters for first screening: A common practice is starting mammography 10 years younger than the age at which the youngest relative was diagnosed. Among women with family history who start screening before age 40, approximately 65% follow this "10-year rule" 4. However, this should be balanced against formal risk calculation.
Breast density impacts screening performance: Recent evidence shows digital breast tomosynthesis (DBT) reduces recall rates and increases specificity compared to standard digital mammography, particularly in women with scattered fibroglandular density and family history 5. DBT also reduced advanced cancer rates in women with extremely dense breasts and family history 5.
Sensitivity increases with age: Mammography sensitivity in women with family history ranges from 63% at ages 30-39 to 84% at ages 60-69, similar to women without family history at each age decade 2. This supports earlier screening initiation rather than different screening technology for younger women with family history.
Common Pitfalls to Avoid
Don't assume all family history confers equal risk: Second-degree relatives (grandmother, aunt) have less impact on screening recommendations than first-degree relatives 6. The increased awareness and earlier detection benefits are primarily seen with first-degree family history.
Don't skip formal risk assessment: Simply having one first-degree relative may not elevate lifetime risk to ≥20%. Use validated risk models to determine if supplemental MRI screening is warranted 1.
Don't forget genetic counseling referral: If the affected relative was diagnosed ≤50 years old, had bilateral disease, or if there are multiple affected relatives, genetic testing should be strongly considered as this changes screening recommendations significantly 7, 1.
The evidence consistently shows that women with first-degree family history benefit from earlier and more intensive screening, with higher cancer detection rates and smaller tumor sizes at diagnosis compared to those without family history 3, 6, 2.